These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 29350068)
1. Primary Liver Cancers-Part 1: Histopathology, Differential Diagnoses, and Risk Stratification. Jiang K; Al-Diffhala S; Centeno BA Cancer Control; 2018; 25(1):1073274817744625. PubMed ID: 29350068 [TBL] [Abstract][Full Text] [Related]
2. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy]. Tischoff I; Tannapfel A Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632 [TBL] [Abstract][Full Text] [Related]
3. Preneoplastic lesions in the liver: Molecular insights and relevance for clinical practice. Desjonqueres E; Campani C; Marra F; Zucman-Rossi J; Nault JC Liver Int; 2022 Mar; 42(3):492-506. PubMed ID: 34982503 [TBL] [Abstract][Full Text] [Related]
4. Primary Liver Cancers, Part 2: Progression Pathways and Carcinogenesis. Jiang K; Centeno BA Cancer Control; 2018; 25(1):1073274817744658. PubMed ID: 29353494 [TBL] [Abstract][Full Text] [Related]
5. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis]. Tátrai P Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466 [TBL] [Abstract][Full Text] [Related]
6. The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma. Patsenker E; Wilkens L; Banz V; Osterreicher CH; Weimann R; Eisele S; Keogh A; Stroka D; Zimmermann A; Stickel F J Hepatol; 2010 Mar; 52(3):362-9. PubMed ID: 20137822 [TBL] [Abstract][Full Text] [Related]
7. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules. Kwon Y; Lee SK; Kim JS; Ro JY; Yu E Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757 [TBL] [Abstract][Full Text] [Related]
8. Fine needle aspiration biopsy of hepatocellular carcinoma and hepatocellular nodular lesions: role, controversies and approach to diagnosis. Wee A Cytopathology; 2011 Oct; 22(5):287-305. PubMed ID: 21762411 [TBL] [Abstract][Full Text] [Related]
16. Differential diagnosis of malignant epithelial tumours in the liver: an immunohistochemical study on liver biopsy material. Al-Muhannadi N; Ansari N; Brahmi U; Satir AA Ann Hepatol; 2011; 10(4):508-15. PubMed ID: 21911893 [TBL] [Abstract][Full Text] [Related]
17. A practical diagnostic approach to hepatic masses. Vyas M; Jain D Indian J Pathol Microbiol; 2018; 61(1):2-17. PubMed ID: 29567877 [TBL] [Abstract][Full Text] [Related]
18. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma. Shiran MS; Isa MR; Sherina MS; Rampal L; Hairuszah I; Sabariah AR Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797 [TBL] [Abstract][Full Text] [Related]
19. The multidisciplinary management of gastrointestinal cancer. The diagnostic and therapeutic approach for primary solid liver tumours in adults. Verslype C; Libbrecht L Best Pract Res Clin Gastroenterol; 2007; 21(6):983-96. PubMed ID: 18070699 [TBL] [Abstract][Full Text] [Related]
20. Atypical large well-differentiated hepatocellular carcinoma with benign nature: a new clinical entity. Kudo M Intervirology; 2004; 47(3-5):227-37. PubMed ID: 15383732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]